The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

What is Cancer? — General Information, Types, and Modern Approaches

A comprehensive overview of cancer biology, classification, risk factors, prevention strategies, and contemporary treatment paradigms including precision oncology, immunotherapy, and multidisciplinary care.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is What is Cancer? — General Information, Types, and Modern Approaches?

Cancer is a heterogeneous collection of more than 200 distinct diseases unified by the hallmarks of malignancy: sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, induction of angiogenesis, and capacity for invasion and metastasis. The disease arises from accumulated genetic and epigenetic alterations that disrupt normal cellular homeostasis, with tumor heterogeneity driving treatment resistance and progression.

Cancer classification has evolved beyond traditional anatomic-histologic categorization to incorporate molecular subtyping based on driver mutations, gene expression profiles, and microenvironment characteristics. Major categories include carcinomas (epithelial origin, ~85%), sarcomas (mesenchymal origin), leukemias and lymphomas (hematologic), and central nervous system tumors. Modern classification integrates biomarkers such as HER2, EGFR, BRAF, BRCA, MSI, PD-L1, and tumor mutational burden to guide therapy selection.

The contemporary therapeutic armamentarium includes surgery, radiation therapy, cytotoxic chemotherapy, hormonal therapy, targeted molecular agents, immunotherapy (checkpoint inhibitors, CAR-T cells, bispecific antibodies), and emerging modalities such as antibody-drug conjugates and tumor-agnostic therapies. Treatment is increasingly personalized through comprehensive genomic profiling, liquid biopsy monitoring, and multidisciplinary tumor board decision-making to optimize outcomes.

Symptoms

Unexplained weight loss exceeding 5% of body weight
Persistent fatigue not relieved by rest
Palpable mass, lump, or thickening anywhere in the body
Changes in bowel or bladder habits, persistent constipation or diarrhea
Non-healing sores, ulcers, or skin lesions with changing characteristics
Unusual bleeding or discharge from any body orifice
Persistent cough, hoarseness, or difficulty swallowing for more than 3 weeks

Risk Factors

Tobacco use (responsible for ~30% of cancer deaths)
Obesity and sedentary lifestyle (~20% of cancers)
Alcohol consumption (head/neck, esophageal, liver, breast cancers)
Chronic infections (HPV, HBV/HCV, H. pylori, EBV, HHV-8)
Environmental and occupational carcinogens (asbestos, benzene, radon)
Ultraviolet and ionizing radiation exposure
Inherited genetic predisposition (BRCA1/2, Lynch syndrome, Li-Fraumeni)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Any new persistent symptom lasting more than 2-3 weeks
  • Discovery of a lump, mass, or unusual swelling
  • Unexplained weight loss, fever, or night sweats
  • Family history of cancer warranting genetic counseling
  • Routine age-appropriate cancer screening (colonoscopy, mammography, low-dose CT)
  • Abnormal screening test results requiring follow-up evaluation
  • Change in size, color, or character of skin lesions

Treatment Methods

01
Surgical resection with curative intent for localized disease
02
Radiation therapy: external beam, brachytherapy, stereotactic body radiotherapy
03
Cytotoxic chemotherapy: neoadjuvant, adjuvant, or palliative regimens
04
Targeted molecular therapy guided by genomic profiling (TKIs, monoclonal antibodies)
05
Immunotherapy: checkpoint inhibitors (anti-PD-1/PD-L1, anti-CTLA-4), CAR-T cell therapy
06
Hormonal therapy for hormone-receptor-positive cancers (breast, prostate)
07
Multidisciplinary supportive care, palliative medicine, and survivorship programs

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.